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1. Introduction     
Cardiovascular disease is one of the major social health problems. Heart attacks, in 
particular, are a major social concern because of the unpredictable and silent way they 
develop. Recently, it was reported that the incidence of myocardial infarction has decreased 
significantly (Yeh et al., 2010). However, some unlucky patients are unaware that they are at 
risk for the life threatening disease. We must acknowledge that while the default setting is 
good health, there is always an onset to a disease and never to a return to good health. This 
onset results in “silent“ angina, and finally a “silent“ attack can happen. In fact, Dutch 
researchers estimated that 43% of heart attacks went unrecognized (de Torbal et al., 2006). 
Our ultimate aim was to predict a heart attack, or at least to quantitatively analyze the heart 
condition, based on the belief that it is possible to predict a heart attack by observing 
fluctuations in heartbeat intervals. Fluctuation analysis first appeared in the physical 
literature a long time ago (Peng et al., 1995). However, strong empirical evidence of its 
accuracy and usefulness must still be collected. 
Traditionally, cardiac studies have employed heart rate variability (HRV) to detect the onset 
of cardiac problems, including disorders of the autonomic nervous system. Problems arise, 
however, when patients are previously assumed to be healthy before the appearance of 
symptoms associated with HRV. An earlier marker is necessary because the early 
identification of symptoms aids in the prevention of the onset of chronic diseases. 
Detrended fluctuation analysis (DFA) (Peng et al., 1995) was proposed as a potentially 
useful method for detecting the signs of cardiovascular disease (See Stanley et al., 1999); 
although DFA has not yet been developed as a practical medical tool, such as the 
electrocardiogram (EKG). (We prefer the abbreviation “EKG” to “ECG,” with due respect to 
the inventor, Dutch physiologist, Nobel laureate, Willem Einthoven.)  
We recently tested the practical usefulness of DFA by using the heart of crustacean-animal 
models. In the test, we successfully showed that DFA could distinguish between intact and 
isolated hearts (Yazawa et al., 2004). In that study, we found out that the scaling exponent of 
the isolated hearts shifted and approached to 0.5 without exception. In turn, the scaling 
exponent of the intact hearts showed a value of about 1.0 without exception. As a result, we 
realized that DFA was reliable and useful because DFA was likely able to accurately reflect 
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physiology. Unlike other methods like HRV, the value of DFA was that it has a baseline 
value of one (1), like a standard body temperature (37), a standard blood pH (7.4), and so on. 
Thus, we thought DFA was a simple tool. One (1) is nonlinearly determined a “healthy” 
outcome resulting from complex interactions between the structure and function of 
molecules, cells, and organs. Thereby, we hoped that DFA could determine the state of 
health “numerically.” DFA seemed to not only reflect the state of the heart itself but also the 
(cardiac) nervous system. We considered that DFA might be used to detect the onset of 
cardiac problems, including disorders of the autonomic nervous system.  
In this chapter, we provide empirical evidence of the practical usefulness of DFA and a new 
EKG amplification device that facilitates automatic DFA computation in practical use. The 
fluctuation analysis (i.e., DFA) was a potentially helpful early detection tool, as it revealed 
information that was not provided by EKG data.    
2. Materials and methods 
2.1 Peak detection of the heartbeat  
Interval analysis requires detection of the precise timing of the heartbeat. A consecutive and 
perfect detection without miscounting is desirable. According to our preliminary test, 
approximately 2,000 consecutive heartbeats are required to obtain a reliable scaling 
exponent computation. We thought that the longer recording time resulted in a more 
accurate diagnosis. However, we found out that recording for longer than 2,000 beats was 
not helpful. We first reached this conclusion in model animal experiments. The ideal 
number of about 2,000 consecutive heartbeats is also applicable in human subjects. 
To detect the timing of the heartbeats, both EKG recording and blood flow pulse recording 
are useful. Figure 1 shows an example of the premature ventricular contraction registered 
by both EKG and finger pulse recordings. Note the difference between Figure 1 A and B. 
Electrical excitation of the ventricle did not produce an observable pulse at the finger (see 
Figure 1A); in turn, an electrical excitation of the ventricle of the identical heart sent a small 
pressure pulse to the finger, which is indicated by an arrowhead (see Figure 1B). No matter 
what recording method was used, difficulty first arose when recording the timing of the 
heartbeats. The baseline drift of the commercial recording system presented the primary 
obstacle. When we saw the drift and contaminated the electric power-line noise, we were 
totally unable to detect 2,000 consecutive beats.  
 
 
 
Fig. 1. Extrasystolic heartbeats in a 55-year–old man. 
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There was another obstacle: premature ventricular contraction (PVC). Among the “normal” 
subjects (age over 40 years old), about 60% of the subjects had arrhythmic heartbeats, such 
as PVC (Figures 1 & 2). Normally, PVC is believed to be benign arrhythmia, and, in fact, 
many healthy-looking people have exhibited this arrhythmia in our own experience. 
However, this PVC was an obstacle to the perfect detection of the timing of the heartbeat 
because the height of the signal was sometime very small (see Figure 1). If the baseline of the 
EKG recording was extremely stable, the heartbeats were automatically detectable even 
when irregular beats appeared sporadically (see Figure 2). However, in commercial EKG 
recording devices, the baseline of the recording was not as stable as shown in Figure 2.  
Figure 2 shows an example of peak identification. In Figure 2A, the heartbeats were not 
detected by visual observation but by our peak-identification program. Heartbeats No. 5 and 
No. 8 show PVC spikes. In Figure 2B, after the peak identification, the interval time series is 
constructed automatically. This is comparable to the so-called R-R interval time series in 
medicine. The two arrows indicate the correlation between the heartbeats in A and B.   
 
 
Fig. 2. An example of peak identification in a 55-year–old man. 
2.2 EKG recording with stable baseline 
To capture peaks without misdetection, we first needed to know how noise disturbs general 
EKG recordings. Figure 3 shows how false peak identifications occur. Here, 3 EKG 
electrodes (+, -, and ground (Nihonkoden Co. Ltd.; disposable Model Vitrode V) were 
placed on the chest of the subject. The subject was asked to hit his chest with his hands 
during the middle of the recording. Artificial noise-like spikes (4 arrowheads) appeared by 
hitting. They were automatically captured as the “false” heartbeats in this figure.  
We made an EKG amplifier that enabled us to perform stable baseline recordings (see 
Figures 4, 5, & 6). An example set is shown in Figure 4. In the photograph, AC- and DC-EKG 
amplifiers, a 100-times amplifier, an analogue digital converter, and a USB connector can be 
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seen. Nothing was special with respect to the arrangement of the parts, but the important 
issue was that we found out that the time constant for the input stage of the recording must 
be adjusted to <0.22 s (Yazawa et al., 2010a; 2010b, Yazawa & Shimoda, 2010a; 2010b). 
Figure 5 shows how our amplifier works for correct peak observation. The EKG trace is 
very stable. Body movements appeared on the record of the Piezo-electric pressure pulse 
(Finger p. trace), but the movements did not disturb the stable EKG recording (EKG 
trace). 
Figure 6 shows an example of the long-period recording needed to perform instantaneous 
DFA computation. Here, a 15-year-old girl sat on a chair and engaged in fun conversation 
for a period of about 25 min. We used the amplifiers and a small time constant for the 
present study. This facilitated our DFA research. However, in some cases, inevitable noises 
contaminated the recordings, like the data shown in Figure 3. In such case, we removed the 
noises by eye observation on the PC screen in making a heartbeat interval time series. 
However, we have already identified how this problem occurred. It was due to the 
electrodes partially separating from the skin caused by sweating. We can overcome this 
problem by ensuring low smear clean skin. 
 
 
 
 
Fig. 3. False peaks incorporated into EKG in a 63-year–old man. 
 
 
 
 
 
Fig. 4. An EKG amplifier. 
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Fig. 5. Steady EKG recording during bodily movements in a 59-year–old man. 
 
 
Fig. 6. A long-term EKG recording without obstacle noise in a 15-year–old girl. 
2.3 DFA: Background 
DFA is based on the concepts of “scaling” and “self-similarity” (Stanley, 1995). It can identify 
“critical” phenomena because systems near critical points exhibit self-similar fluctuations 
(Stanley, 1995, Peng et al., 1995, Goldberger et al., 2002), which means that recorded signals 
and their magnified/contracted copies are statistically similar. Self-similarity is defined as 
follows. In general, the statistical quantities, such as “average” and “variance,” of a fluctuating 
signal can be calculated by taking the average of the signal through a certain section; however, 
the average is not necessarily a simple average. In this study, we took an average of the data 
squared. The statistical quantity calculated depended on the section size. The signal was self-
similar when the statistical quantity was λα times for a section size magnified by λ. Here, “α” is 
the “scaling exponent” and characterizes the self-similarity. 
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Stanley and colleagues consider that the scaling property can be detected in biological data 
because most biological systems are strongly nonlinear and resemble the systems in nature 
that exhibit critical phenomena. They applied DFA to DNA arrangement and EKG data in 
the late 80s and early 90s, identified the scaling property (Peng et al., 1995, Goldberger et al., 
2002), and emphasized the potential utility of DFA in the life sciences (Goldberger et al., 
2002). Although DFA technology has not progressed to a great extent, nonlinear technology 
is now widely accepted, and rapid advances are being made in this technology.  
2.4 DFA: Technique 
DFA computation methods have been explained elsewhere (Katsuyama et al., 2003). In brief, 
DFA is performed as follows:  
i. The heartbeat is recorded for 30–50 minutes in a single test because approximately 2,000 
beats are required for determination of the scaling exponent. We recorded heartbeats 
using an EKG or finger pressure pulses.  
ii. Pulse-peak time series {ti} (i = 1, 2, ... , N + 1) are captured from the record by using an 
algorithm based on the peak-detection method. To avoid false detection, we visually 
identified all peaks on the PC screen. Experience in neurobiology and cardiac animal 
physiology is occasionally necessary when determining whether a pulse-peak is a 
cardiac signal or noise.  
iii. Heartbeat-interval time series {Ii}, such as the R-R intervals on an EKG, are calculated as 
follows:  
 { } { }1   ,  1,  2,  ...,  N+= − =i i iI t t i  (1) 
iv. The series {Bk}, upon which we conduct the DFA, is calculated as follows:  
 { } { }1 ,= ⎡ ⎤= − < >⎣ ⎦∑kk jjB I I  (2) 
where < I > is the mean interval defined as: 
 1
N
ii
I
I
N
=< >= ∑  (3) 
v. The series {Bk} is divided into smaller sections of j beats each. The section size j can range 
from 1 to N. To ensure efficient and reliable calculation of the scaling exponent in our 
program, we confirmed by test analysis that the number N should ideally exceed 1,000.  
vi. In each section, the series {Bk} is approximated to a linear function. To find the function, 
we applied the least square method. This function expresses the “trend”—slow 
fluctuations such as increases/decreases in Bk throughout the section size. A “detrended” 
series {B'k}j is then obtained by the subtraction of  {Bk}  from the linear function. 
vii. We calculated the variance, which was defined as:  
 ( ) { }2 2  'k
j
F j B= < >  (4) 
viii. Steps (v) to (vii) are repeated for changing j from 1 to N. Finally, the variance is plotted 
against the section size j. The scaling exponent is then obtained by  
 ( )2 ∝F j jα  (5) 
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Most of computations mentioned above, which are necessary to obtain the scaling exponent, 
are automated. The automatic program gives us a scaling exponent relatively quickly. The 
scaling exponent is approximately 1.0 for healthy hearts and is higher or lower for sick 
hearts. Although we cannot have a critical discussion regarding whether the exponent is 
precisely 1.0, our automatic program can reliably distinguish a healthy heart from a sick 
heart. In this article, we classified the scaling exponent into 3 types, normal, high, and low.       
2.5 EKG and finger pulse 
For human subjects, we used both finger pulse recordings and EKG recordings. For pulse 
recordings, we used a Piezo-crystal mechano-electric sensor connected to a Power Lab 
System (AD Instruments; Australia). For EKG, 3 AgAgCl electrodes (+, -, and ground, 
manufacturer mentioned above) were used. Wires from the EKG electrodes were connected 
to our newly made amplifier (For EKG amplifier, see above). These EKG signals were also 
connected to a Power Lab System. 
2.6 Model animals 
It is very important that animal models be healthy before an investigation. To confirm that all 
the animals used were healthy, we captured them from a natural habitat and examined them. 
We used crustacean hearts because we are familiar with the structure and function of the 
crustacean heart and nervous system. One of the main reasons for using invertebrates was 
that all these animals have a common genetic code (DNA information) for body systems 
such as the cardiovascular system (Gehring, 1998, Sabirzhanova et al., 2009). All animals 
have a pump (the heart) and a controller (the brain).  
2.7 Volunteers and ethics 
Subjects were selected from colleagues in our university laboratories, volunteers who willingly 
visited our exhibition booth and desired have their heart checked, and the staff at NOMS Co. 
Ltd. and Maru Hachi Co. Ltd. All subjects were treated as per the ethical control regulations of 
our universities, Tokyo Metropolitan University and Tokyo Women’s Medical University. 
3. Results 
3.1 Extrasystole: PVC 
Figure 7 shows an example recording of extrasystole. This recording was obtained by a finger 
pulse recording. Large peaks were marked (o). Two small pulses are shown (A and B), which 
are PVCs. Our volunteers said that a PVC is perceived as a "skipped beat" or felt as 
palpitations, although some experienced no special sensation. In a normal heartbeat, the 
ventricles contract after the atria. In a PVC, the ventricles contract first. Therefore, the ejection 
volume is inefficient (see Figure 7). Single beat PVC arrhythmias do not usually pose a danger 
and can be asymptomatic in “healthy” individuals according to physicians. However, there is 
no way to accurately determine if someone is a “healthy” individual, which is the problem. 
That is why we tested DFA as a tool. 
In Figure 7, one can see that there is difference in the pulse configuration between A and B. 
The two beats originated from different sites (a myocardial cell or cluster of myocardial 
cells) inside the ventricle, or at different times from an identical site. This is a typical 
extrasystole arrhythmia, although we did not pay further attention to cardiac physiology 
like the ectopic beat characteristics. For DFA, we just needed to measure the intervals of the 
heartbeats. Theoretically, irregularity itself carries hidden information.  
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Fig. 7. An example of extrasystolic pulsations in a 65-year-old man. 
During the past 4 years, we have encountered about 50 subjects who have extrasystole 
arrhythmia. Among all of our subjects (over 300) from age 2 to age 87, PVCs were not recorded 
in very young people (age < 19). One exception was a student (age 20); he showed benign 
PVCs. Most cases of PVCs were found in subjects over age 50 and about half were male. 
Figure 8 shows the interval time series from the subject in Figure 7. Here, we recorded 1998 
beats. Only 17 PVCs can be seen as downward swings. 
 
 
Fig. 8. A time series of the EKG with some PVCs. The same subject as in Figure 7. 
We found that PVC hearts always exhibited a low scaling exponent (0.7–0.8). Figure 9 shows 
an example. The computation was worked out on the data of Figure 8. The slope in the 
graph shows a straight line, indicating that “scaling” is beautifully constituted over the 
entire range of the box size (10–1000). The scaling exponent for this subject was 0.8095 (see 
inset equation in Figure 9).  
Most PVCs are benign according to physicians’ assessments so long as the PVC does not 
exceed over 10 times per min. The subject (male 65 years old) shown in Figures. 7, 8, and 9 was 
a very active person. He told us he was working at a large electric company. He seemed to 
have no major health problems. He indicated he was not bothered by his PVC. In fact, it 
looked to be benign.  However, on the basis of our DFA results, we do not agree that PVCs are 
always benign. His scaling exponent was 0.8, which is not perfect health in terms of fluctuation 
analysis. We would say the subject’s health is dependant upon other factors. Therefore, we 
should treat individuals one by one. Everyone has a unique genomic blue print (DNA). The 
genetic code for the structure and function of life is never the same in any 2 individuals.  
Another case study involves a volunteer we worked with for over 6 years. She has so-called 
benign PVCs. She is a German-American (age 58) living in Virginia, USA. She often told us 
that her palpitations (about 10 times per one hour) were uncomfortable when they occurred 
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(data not shown). Her scaling exponents were 0.7–0.8. She said that the PVCs were 
annoying. She was very nervous to have her PVCs compared to this male subject (Figures 7, 
8, and 9). It is known that repetitive PVC leads to ventricular tachycardia. We so far do not 
have good solution for the problem of the low exponent. 
 
 
Fig. 9. DFA results for the subject shown in Figures 7 and 8. 
3.2 Arrhythmia with dialysis 
When we presented our work at an exhibition, Innovation Japan 2009, we met a 
representative from a company who had an interest in healthcare issues. According to his 
proposal, we recorded his EKGs and finger pulses (shown in Figures 1 & 2). We brought 
back his data to the university laboratory and started DFA analysis. 
Figure 10 shows the results. In A, the time series data of 4265 heartbeats is shown. In B, the 
results of the calculation from the entire range of the box size, 10–1000, is shown. This box 
size is our normal calculation procedure. In C, the DFA results on a small box size of 30–110 
are shown. The slope gives the scaling exponent, calculated by least mean square 
approximation, which was 1.1502. In D, the DFA results on a box size of 120–270 are shown. 
The scaling exponent was 0.6283. 
We noticed that his heartbeat exhibited PVC-like arrhythmia (Figures 1, 2, & 10A). We were 
not 100% sure that his arrhythmia was PVC. We wondered how and why his arrhythmic 
beats were generated. After DFA computation was completed, we found that the slope was 
not a straight line (Figure 10B). The scaling exponent calculated from a small box size (30–
110) was 1.15 (see Figure 10C). While 1.15 is within the normal value, we were concerned 
that it was a value higher than 1.0. In turn, his scaling exponent from a large box size (120–
270) was extremely low, 0.6 (see Figure 10D). We could at least say that his health was not 
perfect; we wanted to recommend that he see a doctor. 
Since he did not provide us with any personal health information about himself, we 
believed that he was normal when we took the recording. However, the results were not 
normal. It looked like PVC, but we were not sure. Then, we discussed his results in the 
laboratory, and decided to share our concerns about his heart. We made a telephone call to 
him, and stated: “I am not a physician. I am just a neurobiologist. However, I would like to 
suggest you visiting a cardiologist based on your data.” He then replied that he already 
knew that he had skipped heartbeats, and he was regularly visiting a physician three times a 
week. He further explained that he has been on dialysis for about 20 years. The sickness 
started in his early 30s. He and his doctor always talked about the state of his heart. He 
thanked us for contacting him.  
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Fig. 10. DFA results from patient on dialysis. Male 55 years. 
We felt that he was doubtful of our scientific skill. We passed his examination, which was 
set up without our knowledge. University and corporate collaboration was initiated 
thereafter. 
3.3 PVC with smoking 
Figure 11A shows that we recorded 2338 heartbeats from a subject (a friend of an author) 
when sitting on a chair in a coffee shop. His heartbeat showed PVCs as indicated by some 
short-interval beats (see downward swings in Figure 11A). Three long-interval heartbeats 
(Figure 11A) demonstrate a “skipped” heartbeat. These skipped beats and PVC beats were 
an extrasystolic phenomena. The occurrence of these arrhythmic beats did not exceed 10 per 
min (see Figure 11A). Therefore, we may conclude that his PVC was benign in terms of the 
physicians’ guidelines. However, the scaling exponent was low, 0.7288 (see Figure 12A1 and 
12A2) at a normal sitting state. We confirmed that the PVC exhibited a low scaling exponent.  
He loved smoking cigarettes very much, although a cardiac-scientist recommended that he 
quit. In Figure 11B, 2433 heartbeats were recorded in the coffee shop. When he started 
smoking, recording also began. Skipped beats increased in number during smoking (see 
under-bar periods in Figure 11B). During the smoking period (Figure 11B), the total number 
of PVCs increased. It seemed that the intake of tobacco-related chemicals (we did not 
determine whether it was the nicotine, tar, etc.) into the body quickly pushed the scaling 
exponent toward a much lower value, i.e., from a non-smoking value of 0.7288 (Figure 
12A2) to smoking-value of 0.6195 (Figure 12B2). It was apparent that DFA monitors nervous 
system function as well as cardiovascular function.  
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DFA, therefore, can measure the wellness of the entire body system. However, DFA does 
not tell you in detail, for example, what is wrong with the body system or what local 
element is reacting to the environment.  
Since the results of Figures 11 & 12 were so significant and intriguing, we wanted to 
examine other “smoking” subjects. We finally determined that smokers’ heartbeats were not 
always susceptible to “smoking.” 
 
 
Fig. 11. Time series. A: Non smoking and B: Smoking 58-year–old man. 
 
 
Fig. 12. DFA results on the data in Figure 11. A: Non-smoking, B: Smoking. 
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3.4 Alternans arrhythmia 
Alternans (a period-2 rhythm) was first documented in 1872 by Traube. However, alternans 
did not receive particular attention from doctors until recently; in fact, alternans was 
previously referred to as the harbinger of death (Bragaa et al., 2004, Pieske & Kochskamper, 
2002, Rosenbaum et al., 1994). The phenomenon of alternans is of continuing interest 
nowadays particularly because of its association with myocardial ischemia and cardiac 
arrhythmias. In animal models, we have already reported that the alternans heartbeat 
exhibits a low scaling exponent. This was measured on the heartbeats of crustacean animals 
such as crabs and lobsters (n = 13) (Yazawa et al., 2009). We also encountered human 
alternans subjects (n = 8, 5 Japanese and 3 Americans). Their scaling exponents were low 
(Yazawa et al., 2009).  
Figure 13 shows an example of alternans in which the subject’s heartbeats showed a period-
2 rhythm (Figure 13A). We met him in 2007 at an exhibition called Innovation Japan 2007. At 
that time, he at first told us that he knew that his heart was not normal, and he regularly 
went to see a doctor. He visited us because we presented our DFA method at the exhibition. 
We recorded his heartbeat (Figure 13A). His scaling exponent in September 2007 was 0.6709 
(see Figure 13B and 13C). We explained to him that he had alternans, and we explained the 
condition to the best of our knowledge.  
 
 
Fig. 13. DFA of alternans. Recorded in September 2007 in Tokyo. Subject was in his 60s.  
Two years later, in September in 2009, we returned to the exhibition. We did not expect him 
to visit us again, but he came. We recorded his heartbeat and calculated his scaling exponent 
(Figure 14). To our surprise, the alternans was almost gone, and his scaling exponent was 
higher than in 2007 (see Figure 14A). In fact, there was a noticeable difference in the time 
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series data between 2007 (Figure 13A) and 2009 (Figure 14A). He said that since learning the 
results shown in Figure 13A in 2007, he had been walking to work instead of driving.  
 
 
Fig. 14. DFA of alternans. Recorded again in September 2009 in Tokyo. 
His scaling exponents are compared in Table 1. Three different DFA computations at 
different box sizes are shown. Years 2007 and 2009 are compared. The table shows that his 
scaling exponents were improved in all three areas. The exponents shifted toward the good 
health state, which is ultimately 1.0.  
 
 
Table 1. Comparison of the scaling exponents at different box sizes. Computed from the data 
obtained from the subject shown in Figures 13 and 14. 
Based on these results, we can conclude that DFA was useful in determining that his 
condition had improved. 
3.5 Normal healthy rhythm 
Several volunteers have helped conduct our follow-up test that has lasted for several years. 
The volunteers include the authors, their family members, and university colleagues. Figure 
15 shows an example. A young woman, 26 years old in 2006, who was working in the 
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Fig. 15. DFA follow-up on a healthy subject. Female 27 years old in 2006. 
university’s intellectual property office, was willing to help us as a volunteer for long-range 
follow-up. Since we often worked together, we could obtain information about her everyday 
life if we needed. 
Her scaling exponents have shifted toward a lower value over the course of 4 years. Herein, 
we have described our interpretation of why her scaling exponents gradually changed. This 
case study indicated how and why a once perfectly healthy subject gradually experienced 
stress. 
In 2006, we submitted our patent regarding our DFA method from the university’s 
intellectual property office. At that time, she was a newcomer. She supported us greatly. Her 
heartbeat exhibited a normal scaling exponent of 1.1077 (Figure 15A, in September 2006). 
One could argue that the value of 1.1 is higher than the normal perfect value 1.0. However, 
according to our preliminary guideline, 1.1 is normal. We recorded her heartbeat in 
September of 2006. She was pretty, active in her job, and she was thoughtful to colleagues. 
Most importantly, her exponent was fine. 
In 2008, she lost a loved one. One day, she told us that her grandmother had become 
seriously ill. She returned to her hometown immediately. Her hometown was not located a 
short distance from Tokyo and, therefore, she could not commute back and forth. She stayed 
in her hometown for a while to take care of her grandmother. She only visited the workplace 
occasionally. We did not know the details about her life at that time. Therefore, we just took 
her heartbeat data as usual in September of 2008. Later, we leaned that her loved one had 
recently passed away. 
In September 2009, we again recorded her heartbeat as usual. The Innovation Japan 
exhibition was held in September as well. During the 30 min period of recording of her 
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heartbeat, we talked. While she had recovered from her grandmother’s death, she found her 
present job to be boring. She wanted to be a skilful patent manager and wanted to quit her 
ordinary office job. At the end of the year 2009, she abruptly notified to us that she would be 
leaving since she had accepted another job. Although her salary would decrease, she would 
have the opportunity to perform much higher-level work involving the patent business. 
When we measured her heartbeat in 2006, her exponents were always near 1.0. We believed 
for long time that she represented the perfect scaling exponent. Her EKG data from 2008 and 
2009 were stored deep inside the PC and remained there without receiving attention. 
Recently, we accidentally analyzed her hidden data in August 2010. We discovered that her 
exponents correlated with a shift in her psychology. 
The results are shown in Figure 15. We can trace back what has happened in her life, as 
mentioned above. We can interpret a correlation between the shift of her scaling exponent 
and the shift of her psychological states. In the year 2006, she was a fresh worker after 
finishing her master’s degree, and she had a healthy scaling exponent (Figure 15A, see also 
inset of Figure 15). In the year 2008, she had hard days, and she had stress. In those days, 
her scaling exponent was the worst we hade measured (Figure 15B). In the year 2009, she 
seemed to be recovered although she did not tell us so. However, her scaling exponent was 
not fully recovered to 1.0 (Figure 15C). We now know that she was trying to get a 
promotion, although she never told us until she succeeded in getting a new job. In the 
spring of 2010, she disappeared and we lost contact with her. Nonetheless, her data can 
explain how and why her healthy scaling exponent has shifted.  
This story suggests that DFA measurements might be helpful for monitoring the functioning 
of the entire body system function, including wellness, sickness, and psychology. It is 
apparent that we need to conduct further investigations with additional subjects before 
declaring DFA’s power and ability are great and beyond what we have experienced before 
in the community of health care, medicine, biology, and physics. Biomedical computation is 
a growing field of science. 
4. Discussion 
Heart and skeletal muscle are structurally similar; both exhibit striations. However, unlike 
skeletal muscle, the heart muscle exhibits automaticity—the property of spontaneous 
contractions in the absence of nerve stimuli. Furthermore, the spontaneous contractions are 
generated regularly at their own rate like a clock, or so-called pacemaker. Spontaneity and 
regularity are the most advanced characteristics of myocardial cells, which have been 
achieved in evolution. To alter its robust rhythm, actions by the nerves and hormones to the 
pacemaker are necessary. The force of the action is determined by the number of demands 
coming from the cells in the body via nerves and hormones. Since the cell is the ultimate 
element composing the living body, interaction between cells is a key function in a 
multicellular organism. While all of the elements are nonlinearly connected to each other, 
the interaction is never the same in any 2 individuals because each individual has his/her 
own genome. For example, different cells (individual) respond differently to an antibiotic; 
thus, some are highly resistant, and some are less resistant (Lee et al., 2010). Here is another 
example showing that everybody has their own genetic code: It is believed that a 
medication, clopidogrel, reduces the rate of major vascular events among patients with 
acute coronary syndromes and atrial fibrillation. A recent study implied that the benefits of 
clopidogrel were attenuated in patients with genetic variants (Paré et al., 2010). Thus, 
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everyone must be checked and considered independently when applying DFA. If we find a 
single exception, we should throw out our theory because it should not happen in terms of a 
nonlinear way of thinking. We so far have confirmed that PVC subjects have a low scaling 
exponent. There have been no cases where a PVC subject had a value higher than 1.0. We 
could not accept such a discrepancy. We have so far never found a paradox. We are able to 
explain all data under the criterion that 1.0 means wellness and a variation from 1.0 means 
sickness. However, there is a problem with the criterion: the border between wellness and 
sickness has not yet been established. Everlasting investigation is the only solution for 
confirming our theory is accurate.  
What is wellness of life? Wellness is the state in which an individual can generate 1/f 
rhythm from the heartbeat (Kobayashi and Musha, 1993). The important point is whether 
the rhythm is 1/f or not. In this article, we showed that DFA works without exception. If 
you have a scaling exponent of 1.0, then you are healthy. If your scaling exponent is higher 
or lower than 1.0, something is wrong with you. The scaling exponent of 1.0 is the perfect 
state of life. To our surprise, only 10% of our subjects belonged to the perfect state (n = 300, 
human; the number was greater in animal models including lobsters, crabs, frogs, and 
insects). 
Synchronous contractions of the cardiac muscles are a fundamental functional requirement 
for the heart to work as a pump. Further, this synchrony is established by electric coupling 
between the muscle cells. This synchronous and regular automaticity assures a constant 
flow of circulation and is widely observable throughout the animal kingdom, from 
invertebrates to vertebrates, i.e., from insects and lobsters to humans. This explains why our 
experiments on model animals were successful and useful for human physiology.  
Our experiments on crustacean hearts (Yazawa et al., 2004) led us to the conclusion that 
DFA distinguished isolated hearts from intact hearts. From this conclusion, we deduced that 
DFA was useful for detecting the preliminary stage of sickness of the cardiovascular system.  
The present case studies verified this deduction.  
The periodicity of contractions is a common and important characteristic of the heart. If 
regularity is disturbed for some reason, clotting/coagulation of the blood cells easily occurs. 
Thus, irregularity is a disadvantage for wellness. Rate change in the heartbeat normally 
occurs in a gradual manner in various time courses, either in a slow response or quick 
response. A mixture of the various time courses is required for wellness. In principle, DFA 
looks at the degree of mixture of the time courses. Skipping heartbeats (PVC) and alternans 
(2 beats) exhibited less dynamical changes in rate. This was well sensed by DFA as a low 
scaling exponent.  
A gradually and dynamically changing heart rate is proof of wellness and a healthy scaling 
exponent of 1.0. Uncomfortable and adverse stimulation from the environment can interfere 
with the periodicity of cardiac contractions, e.g., stress-induced arrhythmic heartbeats. A 
typical example of stress-induced arrhythmia is a sudden reflexive slow-down in the rate of 
the heartbeat observed during a shadow stimulation (Mashimo et al., 1976, Yazawsa et al., 
1977, see also Gwilliam, 1963 for shadow reflex). Changes in rate naturally reflect changes in 
external and internal environments. Dynamic change is itself normal. However, if 
interactions between the nerve signals (neurotransmitters/hormones) and muscle receptors 
are not normal, skipping beats, deficit beats, unstable intervals, and extremely fast beatings 
may occur. This is well sensed by DFA, and DFA will calculate a low scaling exponent as 
described in the present investigations. 
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We declare that DFA can distinguish wellness and sickness. If the scaling exponent is near 
1.0, wellness is confirmed. If the scaling exponents are considerably higher or lower than 1.0, 
a masked condition is a possibility. Unfortunately, we must admit that DFA cannot tell what 
cells or what organ is the origin of that poor state. We cannot determine what is wrong with 
the subject. We admit that there is such a limit in DFA. However, DFA makes a “good” or 
“bad” judgement of health in a quantitative way. 
Myocardial pacemaker cells produce the periodicity of cardiac contractions. The pace is 
determined by the rate of action potentials, which requires strictly controlled ionic flows. 
The ionic flows are controlled by ionic channels equipped on the myocardial cellular 
membrane. The millions of ionic channels work with quasi synchronously in the myocardial 
membrane. However, synchrony is not perfect among the millions of channels. 
Fundamentally, the ionic channels in the cells have electrical properties comprised of 2 
states—open and closed. The consequences of modification/distortion of the open vs. closed 
states are arrhythmic heartbeats, i.e., heartbeat fluctuations. The fluctuation occurs within a 
millisecond in the time scale. From this consideration, we adopted a sampling rate of 1 kHz 
when we recorded heartbeat data. This was a key factor of the recording method, and it led 
us to a successful DFA analysis for determining whether or not subjects were healthy. The 
origin of arrhythmia, therefore, is the membrane of the ionic channels. Sodium (Na) and 
potassium (K) are the major ions that contribute to the rate of cardiac action potentials since 
these ions are present in the blood (and tissue fluid) at the highest concentrations. Other 
ions, such as calcium (Ca), are present in the blood at relatively low concentrations. 
Therefore, the rate of flow of Na/K ions is the key factor determining the heart rate. (We do 
not, however, ignore the contribution of Ca to heart rate.) The equilibrium potential of each 
ion and the membrane potential of the myocardium are important factors for determining 
heart rate. Without any changes in the equilibrium or membrane potentials, the heart rate 
cannot be changed in a constant temperature environment. The pace making mechanism is 
fundamentally robust in function because millions of channels work together in a quasi-
synchronous way. To change this robust pacing function, chemicals (neurotransmitters and 
hormones) must act on receptor-ionic channels (complex molecules). Taken together, ionic 
balance and chemical balance (hormones and neurotransmitters) are the key variables for 
determining the heart rate. DFA indirectly examines this fundamental molecular 
mechanism. Ultimately, wellness and sickness are related to the ionic mechanism of nerves 
and muscles that receive influences from the chemical ingredients in the blood. We trust that 
the state of the blood and nerves plays a pivotal role in the state of wellness.  
Gradual changes from wellness to sickness are invisible on ordinary EKG recordings. 
Nevertheless, pumping hearts may carry hidden information about wellness or sickness, 
and we can extract this information from the pattern of the heartbeats. Extremely irregular 
heartbeats may indicate sickness, the worst-case scenario being a heart attack.  
Heart attacks do not recur with the precision of a timed life cycle, or have the signature of 
sudden psychological shock. However, we believe that they obey the laws of physics, which 
means that we should be able to predict their recurrence. For this purpose, we must employ 
physics and mathematics in addition to biology and medicine. In Chinese medicine, 
physicians feel the pulse of patients to make diagnoses. A skilled physician’s nervous 
system seems to function like a computer and performs miraculous feats. This fact indicates 
that pulses and heartbeats carry hidden information about a patient’s wellness or sickness. 
However, man-made machines have not been able to mimic this ability of physicians, even 
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though more than a hundred years have elapsed since the inception of the industrial 
revolution. Despite the historical challenges, we hope to design a machine that can be used 
to detect irregularities in cardiac periodicity. Our new EKG amplifier belongs to such efforts. 
It is almost noise free so long as subjects do not make extremely hard movements of the 
body, the details of which were documented in the present article. 
Based upon our preliminary guidelines, 0.9–1.19 indicates health, 1.2–1.5 indicates sudden 
death, and 0.5–0.89 indicates natural death. In our study, and in the study conducted by 
Peng et al., (1995), the “normal” state has been associated with a scaling exponent of 0.9–1.19 
(our study) and 1.0 (Peng et al.). In the present article, we showed that PVC, a typical 
arrhythmia involving extrasystoles, exclusively lowered the scaling exponent; and alternans, 
an abnormal heart rhythm also known as the “harbinger of death,” also exclusively lowered 
the scaling exponent of heartbeat fluctuation dynamics.  
Moreover, we already found that transplanted human hearts (n = 3) exhibit a scaling 
exponent as high as 1.2 (Yazawa et al., 2006), and hearts with ischemic disease (n = 5) exhibit 
a scaling exponent of 1.2–1.4 (Yazawa et al., 2008, Yazawa and Tanaka, 2009). However, we 
have made some intriguing observations among our volunteers. We have met a volunteer 
subject (subject was in his late 60s, our colleague in Tokyo) who had received emergency 
medical care for ischemic heart disease. He received a stent placement. He had no 
myocardial cell damage according to his surgeon. We found that he had a normal scaling 
exponent (1.0). In this case, his wife was smart enough to notice her husband’s sickness and 
made the quick decision to call an ambulance; in fact, she protected her husband from 
serious myocardial damage from coronary ischemia. Defibrillator implantation and 
continuous medication for atrial arrhythmia were also associated with a normal scaling 
exponent (subject in his 40s from in Nagoya City, subject in his 60s from Kawasaki City). 
Thus, the scaling exponent may indicate whether defibrillators and/or medications are 
working properly. Therefore, we consider that DFA will aid diagnostic decisions in patients 
with cardiovascular disorders. More case studies are required, although our guideline has 
thus far proved adequate, and we have found no exceptions to it, such as ischemic heart 
disease being associated with a high scaling exponent.  
In this article, we have provided empirical proof of the practical usefulness of DFA. By 
presenting several case studies, we explained how the wellness of subjects could be 
evaluated using heartbeat recordings. Our purpose was to determine whether DFA is a 
useful method for the evaluation of the quality of a normal, healthy state. Our crucial target 
of this successive investigation was to discover the contradictions, if any, of our theory. Our 
preliminary guidelines for the interpretation of scaling exponents are as follows: 1, ideal 
state (wellness); >1, the heart is ready to stop any time; and <1, the heart is stressed, and its 
ionic balance and nerve activity are not ideal. 
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